cilostazol has been researched along with Allodynia in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Cilostazol (CLZ) has pleiotropic effects including neuroprotection in several ravaging central disorders; nonetheless, its potential role in transient central ischemic-induced allodynia and hyperalgesia has not been asserted before." | 8.12 | Cilostazol Alleviates NLRP3 Inflammasome-Induced Allodynia/Hyperalgesia in Murine Cerebral Cortex Following Transient Ischemia: Focus on TRPA1/Glutamate and Akt/Dopamine/BDNF/Nrf2 Trajectories. ( Abdallah, DM; Mohammed, RA; Nassar, NN; Safar, MM; Zaki, OS, 2022) |
| " Cilostazol (CLZ) has pleiotropic effects including neuroprotection in several ravaging central disorders; nonetheless, its potential role in transient central ischemic-induced allodynia and hyperalgesia has not been asserted before." | 4.12 | Cilostazol Alleviates NLRP3 Inflammasome-Induced Allodynia/Hyperalgesia in Murine Cerebral Cortex Following Transient Ischemia: Focus on TRPA1/Glutamate and Akt/Dopamine/BDNF/Nrf2 Trajectories. ( Abdallah, DM; Mohammed, RA; Nassar, NN; Safar, MM; Zaki, OS, 2022) |
| "Co-treatment with cilostazol prevented paclitaxel-induced dedifferentiation of Schwann cell cultures and demyelination in a mixed culture of Schwann cells and dorsal root ganglia neurons." | 1.62 | Cilostazol is an effective causal therapy for preventing paclitaxel-induced peripheral neuropathy by suppression of Schwann cell dedifferentiation. ( Imai, S; Iwamitsu, Y; Koyanagi, M; Matsubara, K; Matsumoto, M; Moriya, A; Nakagawa, S; Nakagawa, T; Nakazato, Y; Ogihara, T; Saigo, M; Yonezawa, A, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zaki, OS | 1 |
| Nassar, NN | 1 |
| Abdallah, DM | 1 |
| Safar, MM | 1 |
| Mohammed, RA | 1 |
| Koyanagi, M | 1 |
| Imai, S | 1 |
| Iwamitsu, Y | 1 |
| Matsumoto, M | 1 |
| Saigo, M | 1 |
| Moriya, A | 1 |
| Ogihara, T | 1 |
| Nakazato, Y | 1 |
| Yonezawa, A | 1 |
| Nakagawa, S | 1 |
| Nakagawa, T | 1 |
| Matsubara, K | 1 |
2 other studies available for cilostazol and Allodynia
| Article | Year |
|---|---|
Cilostazol Alleviates NLRP3 Inflammasome-Induced Allodynia/Hyperalgesia in Murine Cerebral Cortex Following Transient Ischemia: Focus on TRPA1/Glutamate and Akt/Dopamine/BDNF/Nrf2 Trajectories.
Topics: Animals; Brain Ischemia; Brain-Derived Neurotrophic Factor; Carrier Proteins; Cerebral Cortex; Cilos | 2022 |
Cilostazol is an effective causal therapy for preventing paclitaxel-induced peripheral neuropathy by suppression of Schwann cell dedifferentiation.
Topics: Animals; Blood Proteins; Breast Neoplasms; Cell Dedifferentiation; Cell Line, Tumor; Cilostazol; Dem | 2021 |